CALT News and Press, Calliditas Therapeutics AB From 05/28/24

Calliditas Therapeutics Presents Data at the 61st European Renal Association Congress PR Newswire STOCKHOLM , May 28, 2024 /PRNewswire/ -- Calliditas Therapeutics AB (Nasdaq: CALT) (Nasdaq Stockholm: CALTX) ("Calliditas"), today announced the presentations ...

2024-05-28 05:49:18 ET Japanese conglomerate Asahi Kasei ( OTCPK:AHKSY ) ( OTCPK:AHKSF ) on Tuesday proposed to acquire Swedish biopharmaceutical company Calliditas Therapeutics ( NASDAQ: CALT ) for $1.1B.... Read the full article on Seeking Alpha For further det...

Statement by the Board of Directors of Calliditas Therapeutics AB (publ) in relation to the public offer by Asahi Kasei Corporation PR Newswire STOCKHOLM , May 28, 2024 /PRNewswire/ -- The Board of Directors of Calliditas Therapeutics AB (publ) unanimously...

2024-05-23 15:11:04 ET Calliditas Therapeutics AB (publ) (CALT) Q1 2024 Earnings Conference Call May 23, 2024 8:30 AM ET Company Participants Renee Aguiar-Lucander - CEO Richard Philipson - CMO Maria Tornsen - President, North America Fredrik Johansson - CFO ...

Calliditas Q1 report, January - March 2024 PR Newswire STOCKHOLM , May 23, 2024 /PRNewswire/ -- Calliditas Therapeutics AB (NASDAQ: CALTX) ( STOCKHOLM : CALTX) : Target market expansion following full approval in the US JANUARY - MA...

CXApp Inc. (CXAI) is expected to report for quarter end 2024-03-31 Purple Biotech Ltd. (PPBT) is expected to report $-0.15 for Q1 2024 AutoZone Inc. (AZO) is expected to report $35.72 for Q3 2024 Turkcell Iletisim Hizmetleri AS (TKC) is expected to report for Q1 2024 Orkla ASA ADR...

In-Person & Virtual R&D Day: The Anti-Fibrotic Effects of Setanaxib and TARPEYO's Mode of Action In-Person & Virtual R&D Day: The Anti-Fibrotic Effects of Setanaxib and TARPEYO's Mode of Action PR Newswire STOCKHOLM , May 16, 2024 /PRNewswire/...

Invitation to the presentation of Calliditas´s interim report January - March 2024 PR Newswire STOCKHOLM , May 16, 2024 /PRNewswire/ -- Calliditas's interim report for the first quarter, January - March 2024 will be published in Swedish and English on ...

Calliditas Therapeutics to Present Data at ERA 2024 May 23 - 26 in Stockholm PR Newswire STOCKHOLM , May 15, 2024 /PRNewswire/ -- Calliditas Therapeutics AB (NASDAQ: CALT) (NASDAQ STOCKHOLM : CALTX) ("Calliditas"), today announced upcoming data presenta...

2024-05-14 08:01:12 ET More on Calliditas Therapeutics Calliditas Therapeutics AB (publ) (CALT) Q4 2023 Earnings Call Transcript Calliditas releases phase 2 results on head and neck cancer asset setanaxib Seeking Alpha’s Quant Rating on Calliditas Therapeutics...